Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.44 USD -0.31%
Market Cap: 829.5m USD
Have any thoughts about
Cytek Biosciences Inc?
Write Note

Relative Value

The Relative Value of one CTKB stock under the Base Case scenario is 9.81 USD. Compared to the current market price of 6.44 USD, Cytek Biosciences Inc is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CTKB Relative Value
Base Case
9.81 USD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
66
vs Industry
43
Median 3Y
6.9
Median 5Y
6.7
Industry
4.1
Forward
4.1
vs History
vs Industry
0
Median 3Y
-175.6
Median 5Y
-202.2
Industry
32.7
Forward
-107.8
vs History
47
vs Industry
3
Median 3Y
52.8
Median 5Y
54.6
Industry
22.1
vs History
19
vs Industry
1
Median 3Y
-108.3
Median 5Y
-100.3
Industry
33.6
vs History
69
vs Industry
44
Median 3Y
3
Median 5Y
3
Industry
2.6
vs History
66
vs Industry
55
Median 3Y
5.2
Median 5Y
4.9
Industry
3.9
Forward
2.7
vs History
66
vs Industry
62
Median 3Y
8.7
Median 5Y
8.6
Industry
8.6
vs History
vs Industry
0
Median 3Y
-23.7
Median 5Y
-12.7
Industry
18.5
Forward
24.7
vs History
vs Industry
2
Median 3Y
-22
Median 5Y
-22.8
Industry
23.7
Forward
-27.6
vs History
47
vs Industry
4
Median 3Y
34.9
Median 5Y
36.8
Industry
21.4
vs History
33
vs Industry
1
Median 3Y
-42.8
Median 5Y
0
Industry
28.8
vs History
69
vs Industry
37
Median 3Y
4.1
Median 5Y
4.3
Industry
2.4

Multiples Across Competitors

CTKB Competitors Multiples
Cytek Biosciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cytek Biosciences Inc
NASDAQ:CTKB
849.5m USD 4.2 -83.4 -34.3 -24.3
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cytek Biosciences Inc
NASDAQ:CTKB
Average EV/EBITDA: 174.9
Negative Multiple: -34.3
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 513.6
23%
66.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
19%
1.1
US
Danaher Corp
NYSE:DHR
26.7
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.3
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.3
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.1
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.1
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.3
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
52%
0.3

See Also

Discover More
Back to Top